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These guidelines for treatment of STDs reflect recommendations of the MDPH DSTDP and of the CDC STD Treatment 
Guidelines. These outlines focus on STDs encountered in outpatient settings and are not an exhaustive list of effective 
treatments. Please refer to the complete CDC document for more information or call the DSTDP. Clinical and epidemiological 
services are available through the DSTDP including staff to assist healthcare providers with confidential notification of sexual 
partners of patients infected with STDs and/or HIV. Please call the DSTDP for assistance at (617) 983-6940. 
 
 
DISEASE RECOMMENDED TREATMENT ALTERNATIVES 
(use only if recommended regimens are 
contraindicated) 
SYPHILIS 
ADULTS 
PRIMARY, SECONDARY OR EARLY LATENT (<1 YEAR) 
• Benzathine penicillin G 2.4 million units IM once (For penicillin-allergic non-pregnant patients only) 
• Doxycycline 100 mg orally 2 times a day for 14 days OR 
• Tetracycline 500 mg orally 4 times a day for 14 days 
ADULTS 
LATE LATENT (>1 YEAR) OR LATENT OF UNKNOWN 
DURATION 
• Benzathine penicillin G 2.4 million units IM for 3 doses at 1 
week intervals (total 7.2 million units) 
(For penicillin-allergic non-pregnant patients only) 
• Doxycycline 100 mg orally 2 times a day for 28 days OR 
• Tetracycline 500 mg orally 4 times a day for 28 days 
NEUROSYPHILIS • Aqueous crystalline penicillin G 18 - 24 million units per 
day, administered as 3-4 million units IV every 4 hours or 
continuous infusion, for 10-14 days 
• Procaine penicillin 2.4 million units IM once daily PLUS 
probenecid 500 mg orally 4 times a day, both for 10-14 
days 
CHILDREN 
PRIMARY, SECONDARY OR EARLY LATENT (<1 YEAR) 
• Benzathine penicillin G 50,000 units/kg IM once, up to 
adult dose of 2.4 million units 
CHILDREN 
LATE LATENT (>1 YEAR) OR LATENT OF UNKNOWN 
DURATION 
• Benzathine penicillin G 50,000 units/kg IM (up to adult 
dose of 2.4 million units) for 3 doses at 1 week intervals 
(up to total adult dose of 7.2 million units) 
No specific alternative regimens exist. 
CONGENITAL SYPHILIS See complete CDC guidelines. 
HIV INFECTION Same stage-specific recommendations as for HIV-negative persons. 
PREGNANCY Penicillin is the only recommended treatment for syphilis during pregnancy. Women who are allergic should be desensitized 
and treated with penicillin. Treatment is the same as in non-pregnant patients for each stage of syphilis.1
GONOCOCCAL INFECTIONS 
ADULTS, ADOLESCENTS AND CHILDREN ≥45 KG ♦ Ceftriaxone 250 mg IM once 
UROGENITAL, PHARYNGEAL, RECTAL PLUS2
♦ Azithromycin 1 g orally once (preferred) OR 
♦ Doxycycline3 100 mg orally 2 times a day for 7 days 
Note: Use of any alternative regimens for gonorrhea 
should be followed by a test-of-cure4 in one week. 
For urogenital or rectal infections ONLY, and ONLY if 
ceftriaxone is not available: 
♦ Cefixime 400mg orally once 
PLUS
♦ Azithromycin 1 g orally once (preferred) OR 
♦ Doxycycline3 100 mg orally 2 times a day for 7 days   
For severe cephalosporin allergy: 
♦ Azithromycin 2 g orally in a single dose  
ADULTS AND ADOLESCENTS 
CONJUNCTIVAL 
• Ceftriaxone 1 g IM once plus lavage the infected eye with 
saline solution once 
CHILDREN <45 KG • Ceftriaxone 125 mg IM once 
NEONATES 
OPHTHALMIA NEONATORUM 
INFANTS BORN TO INFECTED MOTHERS 
• Ceftriaxone 25-50 mg/kg IV or IM once (maximum 125 mg) 
No specific alternative regimens exist. 
CHLAMYDIAL INFECTIONS 
ADULTS AND CHILDREN AGED >8 YEARS • Azithromycin 1 g orally once OR 
• Doxycycline 100 mg orally 2 times a day for 7 
days 
• Erythromycin base 500 mg orally 4 times a day for 7 days5 OR 
• Erythromycin ethylsuccinate 800 mg orally 4 times a day for 7 days OR 
• Levofloxacin6 500 mg orally once a day for 7 days OR 
• Ofloxacin 300 mg orally 2 times a day for 7 days 
CHILDREN <45 KG AND NEONATES • Erythromycin base or ethylsuccinate 50 
mg/kg/day orally divided into four doses daily 
for 14 days7 
No specific alternative regimens exist. 
PREGNANCY • Azithromycin 1 g orally once OR 
• Amoxicillin 500 mg orally 3 times a day for 7 
days 
• Erythromycin base 500 mg orally 4 times a day for 7 days (or 250 mg 
orally 4 times a day for 14 days) OR 
• Erythromycin ethylsuccinate 800 mg orally 4 times a day for 7 days (or 
400 mg orally 4 times a day for 14 days) 
NONGONOCOCCAL URETHRITIS 
ADULT MALES • Azithromycin 1 g orally once8 OR 
• Doxycycline 100 mg orally 2 times a day for 7 
days 
• Erythromycin base 500 mg orally 4 times a day for 7 days OR  
• Erythromycin ethylsuccinate 800 mg orally 4 times a day for 7 days OR 
• Levofloxacin 500 mg orally once a day for 7 days OR 
• Ofloxacin 300 mg orally 2 times a day for 7 days 
EPIDIDYMITIS9
ADULT MALES 
 
• Ceftriaxone 250 mg IM once PLUS 
• Doxycycline 100 mg orally 2 times a day for 10 days 
• Levofloxacin 500 mg orally once a day for 10 days OR 
• Ofloxacin 300 mg orally twice daily for 10 days 
PELVIC INFLAMMATORY DISEASE (outpatient management) 
ADULT FEMALES • Ceftriaxone 250 mg IM once OR 
• Cefoxitin 2 g IM once plus probenecid 1 g orally once OR 
• Other third generation cephalosporin 
PLUS
• Doxycycline 100 mg orally 2 times a day for 14 days 
WITH OR WITHOUT 
• Metronidazole10 500 mg orally twice a day for 14 days 
See complete CDC guidelines for alternatives. 
PREGNANCY Patients should be hospitalized and treated with the appropriate recommended parenteral IV therapy (see complete 
CDC guidelines). 
 
                                                          
1 Tetracycline/doxycycline contraindicated; erythromycin not recommended because it does not reliably cure an infected fetus; data insufficient to recommend azithromycin or ceftriaxone. 
2 Dual therapy for gonococcal infection now recommended for all patients with gonorrhea regardless of chlamydia test results. 
3 Doxycycline not recommended during pregnancy, lactation, or for children <8 years of age. 
4 Test-of-cure for gonorrhea should be performed with culture or with nucleic acid amplification (NAAT) if culture is not available.  If NAAT positive, confirmatory culture recommended.  If 
treatment failure suspected after alternative regimen use, treat using ceftriaxone 250 mg IM PLUS azithromycin 2 g orally once, and perform test-of-cure in one week.  If treatment 
failure suspected after recommended regimen use, culture, perform antimicrobial susceptibility testing, notify and consult with the state health department, and/or consult with an 
infectious disease specialist, an STD/HIV Prevention Training Center (www.nnptc.org), or CDC.   
5 If patient cannot tolerate high dose erythromycin schedules, change to lower dose for longer (see under pregnancy alternatives). 
6 Quinolones not recommended for use in patients <18 years of age, and are contraindicated in pregnant women. 
7 Efficacy of treating neonatal chlamydial conjunctivitis and pneumonia is about 80%. A second course of therapy may be required. An association between oral erythromycin and 
infantile hypertrophic pyloric stenosis (IHPS) has been reported in infants aged less than 6 weeks treated with this drug. See complete CDC guidelines for more information. 
8 Infections with M. genitalium may respond better to azithromycin. 
9 Recommended regimen of ceftriaxone and doxycycline is for epididymitis most likely caused by gonococcal and/or chlamydial infection.  Given increase in quinolone resistant 
gonorrhea, alternative regimen of ofloxacin or levofloxacin is recommended only if epididymitis is not found to be caused by gonococci or if infection is more likely caused by enteric 
gram-negative organisms. 
10 Consuming alcohol should be avoided during treatment and for 24 hours thereafter. Multiple studies and meta-analyses have not demonstrated an association between metronidazole 
use during pregnancy and teratogenic or mutagenic effects in newborns. In lactating women administered metronidazole, withholding breastfeeding during treatment and for 12–24 
hours after last dose will reduce exposure of infant to metronidazole. 
♦ Indicates revision from previous STD Treatment Guidelines   Version 12-2012 
 DISEASE RECOMMENDED TREATMENT ALTERNATIVES 
(use only if recommended regimens are 
contraindicated) 
CHANCROID 
• Azithromycin11 1 g orally once OR ADULTS 
 • Ceftriaxone 250 mg IM once OR 
• Ciprofloxacin 500 mg orally 2 times a day for 3 days OR 
• Erythromycin base 500 mg orally 3 times a day for 7 days  
 
BACTERIAL VAGINOSIS (BV) 
ADULT FEMALES • Metronidazole 500 mg orally 2 times a day for 7 days OR 
• Metronidazole gel 0.75%, 5 g intravag. once a day for 5 
days OR 
• Clindamycin cream 2%, 5 g intravag. at bedtime for 7 days 
12♦ Tinidazole  2 g orally once daily for 3 days OR 
♦ Tinidazole 1 g orally once daily for 5 days OR 
• Clindamycin 300 mg orally 2 times a day for 7 days OR 
• Clindamycin ovules 100 mg intravag. at bedtime for 3 
days 
13PREGNANCY • Metronidazole 500 mg orally 2 times a day for 7 days OR 
• Metronidazole 250 mg orally 3 times a day for 7 days OR 
• Clindamycin 300 mg orally 2 times a day for 7 days 
 
TRICHOMONIASIS 
,14ADULTS • Metronidazole• Metronidazole 2 g orally once OR 
• Tinidazole 2 g orally once 
 500 mg orally 2 times a day for 7 days 
PEDICULOSIS PUBIS15
 • Permethrin 1% cream rinse applied to affected area and 
washed off after 10 minutes 
• Malathion 0.5% lotion applied for 8-12 hours and washed 
off OR OR 
16• Pyrethrins with piperonyl butoxide applied to affected area 
and washed off after 10 minutes 
• Ivermectin  250 mcg/kg orally once, repeated in 2 weeks 
SCABIES 
17 • Permethrin 5% cream applied to all areas of the body from 
the neck down and washed off after 8-14 hours 
• Lindane
OR 
• Ivermectin 200 mcg/kg orally, repeated in 2 weeks 
 1% 1 oz of lotion or 30 g of cream applied 
thinly to all areas of the body from neck down and 
washed off after 8 hours   
GENITAL HERPES SIMPLEX: See complete CDC guidelines for the management of herpes in pregnancy and in the neonate. 
ADULTS • Acyclovir 400 mg orally 3 times a day for 7-10 days OR 
FIRST CLINICAL EPISODE  • Acyclovir 200 mg orally 5 times a day for 7-10 days OR 
18 250 mg orally 3 times a day for 7-10 days • Famciclovir
OR 
• Valacyclovir 1 g orally 2 times a day for 7-10 days    
 
 ADULTS • Acyclovir 800 mg orally 2 times a day for 5 days OR 
 EPISODIC THERAPY FOR RECURRENCE 400 mg orally 3 times a day for 5 days • Acyclovir OR 
 800 mg orally 3 times a day for 2 days • Acyclovir OR 
• Famciclovir 125 mg orally 2 times a day for 5 days OR 
• Famciclovir 1000 mg orally 2 times a day for 1 day OR 
♦ Famciclovir 500 mg orally once, followed by 250 mg orally 
2 times a day for 2 days OR 
• Valacyclovir 500 mg orally 2 times a day for 3 days OR 
• Valacyclovir 1 g orally once a day for 5 days 
 
ADULTS • Acyclovir 400 mg orally 2 times a day OR 
SUPPRESSIVE THERAPY FOR RECURRENCE • Famciclovir 250 mg orally 2 times a day OR 
• Valacyclovir 500 mg orally once a day OR 
• Valacyclovir 1 g orally once a day 
 
HIV INFECTION Higher doses and/or longer therapy recommended. See complete CDC guidelines. 
GENITAL WARTS 
External or Perianal 
 
 
• PROVIDER-ADMINISTERED 
Cryotherapy with liquid nitrogen or cryoprobe. Repeat applications every 1-2 weeks if necessary 
OR
Podophyllin resin 10%-25%19 in a compound tincture of benzoin. Limit application to < 10 cm2 
and to < 0.5 ml. No open wounds or lesions should exist in the area of application. Allow to air 
dry. Wash off 1-4 hours after application. Repeat weekly if necessary OR 
Trichloroacetic acid (TCA) or bichloroacetic acid (BCA) 80% -90%. Apply small amount only 
to warts. Allow to dry. If excess amount applied, powder with talc, baking soda or liquid soap. 
Repeat weekly if necessary OR
Surgical removal 
 
• PATIENT-APPLIED 
Podofilox 0.5% solution or gel. Apply 2 times a day for 3 days, followed by 4 days of no 
therapy, 4 cycles max. Total wart area should not exceed 10 cm2 and total volume applied daily 
not to exceed 0.5 ml. OR
Imiquimod 5% cream. Apply once daily at bedtime 3 times a week for up to 16 weeks. Wash 
treatment area with soap and water 6-10 hours after application. OR
♦ Sinecatechins 15% ointment.,20 Applied 3 times a day for up to 16 weeks. Do not wash off. 
Urethral 
Meatus 
 
Cryotherapy 
with liquid 
nitrogen OR 
Podophyllin 
10%-25% in a 
compound  
tincture of 
benzoin. 
Treatment area 
must be dry 
before contact 
with normal 
mucosa. 
Repeat weekly 
if necessary. 
Vaginal 
 
 
Cryotherapy with 
liquid nitrogen. 
Cryoprobe not 
recommended (risk 
of perforation and 
fistula formation) OR 
TCA or BCA 80%-
90%. Apply small 
amount only to 
warts. Allow to dry. If 
excess amount 
applied, powder with 
talc, baking soda or 
liquid soap. Repeat 
weekly if necessary. 
Anal 
 
 
Cryotherapy with liquid nitrogen 
OR 
TCA or BCA 80%-90%. Apply 
small amount only to warts. Allow 
to dry. If excess amount applied, 
powder with talc, baking soda or 
liquid soap. Repeat weekly if 
necessary OR
Surgical removal  
 
Many persons with anal warts may 
also have them in the rectal 
mucosa. Inspect rectal mucosa by 
digital examination or anoscopy. 
Warts on the rectal mucosa should 
be managed in consultation with a 
specialist. 
 
                                                          
11 Because data are limited concerning efficacy of ceftriaxone and azithromycin regimens in HIV-infected persons, these regimens should be used for such patients only if follow-up can 
be ensured. 
12 Consuming alcohol should be avoided during treatment and for 72 hours thereafter. Tinidazole safety during pregnancy not established. Interruption of breastfeeding is recommended 
during treatment and for 3 days after last dose. 
13 Oral therapy preferred for treatment of pregnant women with BV because of possibility of subclinical upper genital tract infection. 
14 Regimen of 7 days of metronidazole may be more effective than single dose metronidazole in women coinfected with trichomoniasis and HIV. 
15 Lindane no longer recommended because of toxicity. Pregnant or lactating women should be treated either with permethrin or pyrethrins with piperonyl butoxide. 
16 Ivermectin not recommended for pregnant or lactating women, or children who weigh <15 kg. 
17 Lindane no longer recommended as first line therapy because of toxicity. Lindane not to be used immediately after a bath, in persons with extensive dermatitis and women who are 
pregnant or lactating, or children aged < 2 years. 
 Famciclovir efficacy and safety not established in patients <18 years of age. 
 Imiquimod, sinecatechins, podophyllin, and podofilox should not be used during pregnancy. 
 Sinecatechins not recommended for HIV-infected persons, immunocompromised persons, or persons with clinical genital herpes. 
18
19
20
 
 
♦ Indicates revision from previous STD Treatment Guidelines   Version 12-2012 
